RFX6 and type 2 diabetes mellitus: A recent study also demonstrated that RFX6 knockdown in primary human islets reduced GSIS to the level seen in islets from donors with type 2 diabetes, through transcriptionally dysregulated vesicle trafficking, exocytosis and ion transport pathways [14].